Funding
Every year we help thousands of people with psoriasis and psoriatic arthritis via our websites, helpline, publications and through our research programme.
We rely on the generosity of people like you to help us continue our vital work. From becoming a member through to fundraising, regular giving through to leaving a legacy, there are lots of ways that you can donate.
With no funding from Government or the Department of Health, we really do depend on your support to help us achieve our aims.
For more information on the Funding and Expenditure of the Psoriasis Association, please download our annual Our Achievements report:
Our Achievements 2024 Audited Accounts 2024
Our Achievements 2023 Audited Accounts 2023
Our Achievements 2022 Audited Accounts 2022
Our Achievements 2021 Audited Accounts 2021
The Psoriasis Association receives funding from the following pharmaceutical companies to support some of its activities and projects (AbbVie, Almirall, Boehringer Ingelheim, Bristol Myers Squibb (BMS), Dermal Laboratories Ltd, Johnson & Johnson Innovative Medicine, Medac Pharma, Novartis, T&R Derma and UCB.
These pharmaceutical companies have no influence over the conduct or content of any of the Psoriasis Association’s activities and projects.